Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01658059
Other study ID # rcauhr-HMO-CTIL
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2012
Est. completion date December 2015

Study information

Verified date March 2019
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pharmacological interventions to aid behavior management's techniques are commonly used in pediatric dentistry. The aim of the medicaments is to control behavior and allow safe completion of a dental procedure. Homeopathic remedy is safe and can be effective to control behavior and decrease anxiety in children during dental treatment.

Aim: 1. To explore the efficacy of homeopathic drugs in decreasing children's dental anxiety before dental treatment.

2. To assess the effectiveness of homeopathic remedy in facilitating dental treatment for anxious children.

Methods: prospective, double-blind study. Thirty healthy children (5-12 years-old) will receive homeopathic remedy\placebo before dental treatment. Anxiety reduction will be measured using: saliva cortisol levels, saliva α-amylase levels, facial image scale (FIS), and Houpt behavior scale.

Expected results: the homeopathic remedy will reduce anxiety and increase child cooperation during dental treatment.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date December 2015
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 12 Years
Eligibility Inclusion Criteria:

- Dental anxiety

- Needs at least 2 dental treatment appointments

Exclusion Criteria:

- Medically compromised

- Cooperative, needs less than 2 dental treatment appointments

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Homeopathic remedy
drops of the homeopathic remedy will be taken twice a day before the treatment and once on the morning of the treatment day.
Placebo
drops of the placebo will be taken twice a day before the treatment and once on the morning of the treatment day.

Locations

Country Name City State
Israel Hadassah Medical Organization Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reducing Children's Anxiety Measuring levels of salivary cortisol and salivary a-amylase levels before dental treatment and after dental treatment . Each dental apointment, aproximatly 30 minutes on the average
See also
  Status Clinical Trial Phase
Completed NCT05663619 - Virtual Reality Distraction and Dental Anxiety Among Anxious Pediatric Patients N/A